Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: an evidence-based clinical practice guideline (updated version)
Mil. med. res. (Lond.); 7 (41), 2020
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness,
coronavirus disease 2019 (COVID-19), affecting more than seventeen million people around the world. Diagnosis
and treatment guidelines for clinicians caring for patients are needed. In the ...
Chimioprévention/méthodes, Infections à coronavirus/diagnostic, Infections à coronavirus/traitement médicamenteux, Pneumopathie virale/diagnostic, Pneumopathie virale/traitement médicamenteux, Pandémies/prévention et contrôle, Betacoronavirus/effets des médicaments et des substances chimiques, Pratique factuelle/méthodes, Antirétroviraux/usage thérapeutique, Lopinavir/usage thérapeutique, Chloroquine/usage thérapeutique, Récepteurs à l'interleukine-6/usage thérapeutique, Hydroxychloroquine/usage thérapeutique, Plasma sanguin/immunologie